As peptide-based therapeutics continue to expand, understanding and controlling aggregation behavior has become essential for ensuring drug safety and efficacy. Join our upcoming webinar to explore peptide aggregation mechanisms and how Size Exclusion Chromatography (SEC) can be applied to characterize these critical quality attributes: https://bit.ly/436ilBq
Phenomenex
Biotechnology Research
Torrance, CA 45,222 followers
Enabling scientists inside the lab to create a better world outside.
About us
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. Phenomenex is proud to be part of Danaher, a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. As part of Danaher, Phenomenex is connected to a uniquely broad ecosystem of expertise, technologies,and capabilities. Together, we partner closely with customers to help solve their toughest challenges with greater speed and certainty. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow.
- Website
-
http://phenomenex.com
External link for Phenomenex
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Torrance, CA
- Type
- Public Company
- Founded
- 1982
- Specialties
- Chromatography, HPLC/UHPLC, Gas Chromatography, Preparative Chromatography, Bulk/Process Media, Oligonucleotide Separation/Purification, Sample Preparation, Accessories/Equipment, Mass Spectrometry, Biotechnology, Cannabis Testing , Pharmaceutical/Biopharmaceutical, Preparative Columns, Philanthropy, Environmental, Separation Science, Chemistry/Biochemistry, Core-Shell Technology, Chiral, Column Protection, QuEChERS, Simplified Liquid Extraction, and Solid Phase Extraction (SPE)
Locations
-
Primary
Get directions
411 Madrid Ave
Torrance, CA 90503, US
Employees at Phenomenex
Updates
-
Enjoy lunch at HPLC 2026 accompanied by insights you can use! Join our lunch seminar "Assay to Aggregates: Chromatographic Workflows for Therapeutic Peptides and Their Unique Impurities" with Sean Orlowicz, Principal Market Development Manager, Pharmaceutical. 🗓️ Monday, June 8 | 12:30 PM - 1:30 PM 📍 White River E Explore strategies for tackling complex peptide workflows and gain practical perspectives from our experts. Then, keep the conversation going with our team at Booth #105. 🔗 See our full HPLC agenda: phenomenex.com/hplc2026 #HPLC2026 #Chromatography #SeparationScience #LifeSciences #AnalyticalChemistry #Phenomenex
-
-
Join us for an upcoming interactive webinar on Sustainable Strategies for High Sensitivity Hormone and Biomarker Analysis for Clinical Research LC-MS/MS Methods! Our experts from Phenomenex will cover: • Low-level steroid extraction using SLE • Quantitative LC-MS/MS analysis of methylmalonic acid (MMA) in human serum • Quantitation of underivatized estrogens without derivatization Featuring presentations from: • Rajashree Chakravarti, PhD • Timothy Fassette • Stephanie Marin Register now: https://bit.ly/4nmwvHY #clinicalresearch #forensicstox #sampleprep #biomarkers #MSACL
-
-
☕ Join us for breakfast at ASMS! Seminar Topic: Achieving Longer LC‑MS/MS Uptime with Advanced Column Design 📍Tuesday, June 2nd from 7:00 AM - 8:15 AM 📍San Diego Convention Center | Room 33C Learn how column durability impacts high-throughput LC-MS/MS workflows through a comprehensive 75 analyte urine toxicology panel. Seats are limited, save your spot ➡️ https://bit.ly/4totLMp #ASMS #LCMS #ClinicalTesting #Chromatography #therapeuticdrug
-
-
Phenomenex reposted this
Understanding your analyte is essential for improved separations, more robust methods, and greater reproducibility. In this live webinar, Lucia Geis Asteggiante, Senior Technical Specialist at Phenomenex, will discuss how analyte characteristics affect analytical results, the main chemical interactions during separation, and practical tips to enhance method development. Reserve your seat here: https://gag.gl/zGQuJD
-
-
Are you using the right SEC pore size? Biozen dSEC chemistries deliver seamless separation from peptides to long nucleic acids, helping you get consistent, high-resolution data from proteins to nucleic acids. Check out this short overview to see how to optimize your SEC workflow: https://bit.ly/4wlhD0O
Are You Using the Right SEC Pore Size? | Biozen dSEC Explained
https://www.youtube.com/
-
sgRNAs are central to CRISPR-Cas targeting, and their quality matters. Join Lara Nercessian, R&D Analytical Scientist at QUALITY ASSISTANCE S.A., in this upcoming webinar to explore how advanced LC methods can support accurate impurity profiling of these complex RNA molecules. Highlights: 📍Different ion-pairing reagents and organic solvents 📍Critical method parameters that affect resolution 📍Practical strategies for optimizing chromatographic conditions following a statistical design Register here ➡️ https://bit.ly/42OvjUb
-
-
Visit Phenomenex at Booth 911 at #TIDES! Our team will be on-site to connect, collaborate, and showcase how Phenomenex supports scientists in solving complex analytical challenges across biopharma workflows. You also won't want to miss our breakfast presentation: 📘 Analytical Strategies for Quantifying Lipid-Conjugated Oligo, GalNAc-Conjugated siRNA, and Antisense Oligonucleotide Therapeutics via Solid Phase Extraction Coupled with LC-MS 📆 May 11 | 8:30am - 9:00am Save your spot: https://bit.ly/4eI0WG6 #TIDESUSA #Biopharma #Oligonucleotides #Peptides #Chromatography #LifeSciences #PeptideTherapeutics
-
-
Phenomenex was proud to connect with scientists, partners, and customers across a range of our April industry events. Bringing people together to share knowledge, solve challenges, and explore what’s next in analytical science is what drives us forward! - WRIB | April 13- 17, 2026 | Dallas, TX | USA - ChemBio Finland | April 15-16, 2026 | Helsinki, Finland | EMEA - Lab Indonesia | April 15-17, 2026 | Jakarta, Indonesia | APAC - Analytica Lab India | April 22-24, 2026 | Mumbai, India | APAC See how we can further support your workflows through our Customer Support Portal: https://bit.ly/4v2y01x
-
-
If you are: 📍An LC and LC‑MS user 📍Newer to the techniques 📍Someone who wants a clear, system‑agnostic protocol to protect columns and instruments during start‑up and shut‑down Join us for this upcoming PhenoAcademy webinar, now offered in two different time zones! Register now ➡️ https://bit.ly/4cSJEnc
-